ViroPharma Beats; All Set To Shine
ViroPharma Inc. (NASDAQ:VPHM) posted fourth quarter 2011 adjusted earnings of 57 cents per share, surpassing the Zacks Consensus Estimate of 42 cents and the year-ago earnings of 47 cents. Full year 2011 earnings of $1.93 per share also beat the Zacks Consensus Estimate of $1.47 and year-ago earnings of $1.64 per share. Higher revenues and [...]
ViroPharma Inc. (NASDAQ:VPHM) posted fourth quarter 2011 adjusted earnings of 57 cents per share, surpassing the Zacks Consensus Estimate of 42 cents and the year-ago earnings of 47 cents. Full year 2011 earnings of $1.93 per share also beat the Zacks Consensus Estimate of $1.47 and year-ago earnings of $1.64 per share. Higher revenues and lower share count boosted earnings.
Higher sales of Cinryze and Vancocin helped improve fourth-quarter and full-year revenues, which came in at $145.6 million and … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards